
    
      The aims of the study are as follows: 1) to continue to unravel the complex biology of lung
      cancer 2) to identify early detection and prognostic markers to guide therapeutic decision 3)
      to define markers of response and/or resistance to drug therapy, and 4) to identify new
      therapeutic and prevention targets.
    
  